Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Immunic Inc (IMUX)

71 + Investors. Track Smart Money conviction in IMUX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +12
Streak
1Q ▲
Buyers last Q
62%

Smart Money Signals — IMUX

Based on 72 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added IMUX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
72 hedge funds hold IMUX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +11% more funds vs a year ago

fund count last 6Q
+7 new funds entered over the past year (+11% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟢

More buyers than sellers — 62% buying

50 buying30 selling
Last quarter: 50 funds were net buyers (32 opened a brand new position + 18 added to an existing one). Only 30 were sellers (10 trimmed + 20 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+24 vs last Q)

new funds entering per quarter
Funds opening a new IMUX position: 7 → 17 → 8 → 32. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

47% of holders stayed for 2+ years

■ 47% conviction (2yr+) ■ 18% medium ■ 35% new
34 out of 72 hedge funds have held IMUX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +146% but shares only +13% — price-driven

Value
+146%
Shares
+13%
Last quarter: the total dollar value of institutional holdings rose +146%, but actual share count only changed +13%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

13 → 7 → 17 → 8 → 32 new funds/Q
New funds entering each quarter: 7 → 17 → 8 → 32. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 56% veterans vs 33% newcomers

■ 56% veterans ■ 10% 1-2yr ■ 33% new
Entry-cohort mix of 78 holders: 44 (56%) are 2+ year veterans, 8 entered 1–2 years ago, and 26 (33%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 20% AUM from major funds

20% from top-100 AUM funds
21 of 72 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.0
out of 10
Moderate Exit Risk
Exit risk score 4.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — IMUX

In 2026 Q1, 50 hedge funds were net buyers of IMUX (32 opened a new position, 18 added to an existing one), while 30 reduced or exited (10 trimmed, 20 sold completely) — a 62% buyer ratio, indicating clear institutional accumulation. 20% of total institutional value in IMUX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +12 funds (more new holders than closures). Total institutional holders: 72.

Hedge Fund Ownership: IMUX

How many hedge funds hold IMUX — quarterly history vs. share price
Quarterly hedge fund ownership of IMUX vs. share price

Market Analysis: IMUX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: IMUX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Immunic Inc (IMUX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much IMUX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 79d ago
IMUX
+27.9%
XLV
+2.8%

IMUX outperformed XLV by +25.1% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 34d ago
IMUX
+17.5%
XLV
+3.9%

Since the filing became public, IMUX outperformed XLV by +13.6% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

8 top-rated funds 0 high-conviction
Consensus
4.1
/ 10
breadth
×
Elite
0.9
/ 10
conviction
Hedge Fund Positioning: IMUX
71 + Investors

Track Smart Money conviction in IMUX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 71 60 18.33%
13F Shares 58M 51M 13.12%
Total Value $70M $29M 145.95%
New Positions 31 8 +23
Increased Positions 17 19 -2
Closed Positions 20 11 +9
Reduced Positions 8 8 -
Total Calls 3 3 -
Total Puts 3 1 200.0%
PUT/CALL Ratio 1.0 0.33 Neutral

Statistics: IMUX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

71 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IMUX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 IMUX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Propel Bio Management, LLC 1.65% 2,344,779 $2.6M
2 Bvf Inc/Il 0.27% 7,652,972 $8.5M
3 Soleus Capital Management, L.P. 0.20% 4,500,000 $5.0M
4 Laurion Capital Management LP 0.19% 3,882,162 $4.3M
5 683 Capital Management, LLC 0.14% 2,450,000 $2.7M
6 Nantahala Capital Management, LLC 0.10% 2,506,491 $2.8M
7 CTC Alternative Strategies, Ltd. 0.06% 24,390 $27K
8 Ikarian Capital, LLC 0.06% 674,662 $749K
9 Scientech Research LLC 0.02% 26,635 $30K
10 Aberdeen Group plc 0.01% 8,243,941 $9.2M
11 Strategies Wealth Advisors, LLC 0.01% 100,000 $111K
12 Lincoln Capital Corp 0.01% 20,400 $23K
13 Simplify Asset Management Inc. 0.01% 438,932 $487K
14 Woodline Partners LP 0.00% 967,152 $1.1M
15 Axq Capital, LP 0.00% 18,151 $20K
16 Adage Capital Partners GP, L.L.C. 0.00% 1,398,600 $1.6M
17 Balboa Wealth Partners 0.00% 12,000 $13K
18 Millennium Management LLC 0.00% 3,779,922 $4.2M
19 Renaissance Technologies LLC 0.00% 919,164 $1.0M
20 Hrt Financial LP 0.00% 493,393 $547K
21 OMERS ADMINISTRATION Corp 0.00% 168,300 $187K
22 Crescent Grove Advisors, LLC 0.00% 10,000 $11K
23 Tower Research Capital LLC (TRC) 0.00% 32,868 $36K
24 Graham Capital Management, L.P. 0.00% 33,297 $37K
25 Hudson Bay Capital Management LP 0.00% 213,017 $236K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Immunic Inc (IMUX)

What does the Smart Money Trend signal show for IMUX?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added IMUX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for IMUX?

More buyers than sellers — 62% buying: Last quarter: 50 funds were net buyers (32 opened a brand new position + 18 added to an existing one). Only 30 were sellers (10 trimmed + 20 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for IMUX holders?

Strong quality — 20% AUM from major funds: 21 of 72 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held IMUX?

47% of holders stayed for 2+ years: 34 out of 72 hedge funds have held IMUX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Immunic Inc (IMUX) following the 2026 Q1 hedge fund 13F filings?

As of today, IMUX has moved +17.5% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of +13.6%. Since the quarter end (March 31, 2026), IMUX has gained +27.9% vs +2.8% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →